Rights and permissions
About this article
Cite this article
Delaying second-line rheumatoid arthritis (RA) therapy can lead to disease activity that is more difficult to control. Inpharma Wkly. 1235, 13 (2000). https://doi.org/10.2165/00128413-200012350-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012350-00026